KYPROLIS carfilzomib 30 mg powder for injection vial

Amgen Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 1d36860f47e9c8ec
Product Name: KYPROLIS carfilzomib 30 mg powder for injection vial
Artg Id: 266773
Artg Name: KYPROLIS carfilzomib 30 mg powder for injection vial
Sponsor: Amgen Australia Pty Ltd
Company Detail Path: /organization/amgen-australia-pty-ltd
Artg Date: 2016-12-19
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/3d7a955e3b693f9af3f4113ed0481eb4.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/e464db495cf3bfc4902fc718ee93cf7d.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

1d36860f47e9c8ec

Type

Standard